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disease. Limited long-term data, however, is available on long DES.
The prospective RESOLUTE 38-mm substudy of the RESOLUTE
Global Clinical Program enrolled patients requiring treatment of
de novo lesions in native coronary arteries with a 38-mm length
ResoluteTM DES (Santa Rosa, CA, Medtronic, PLC).
Methods: The RESOLUTE 38-mm substudy includes the RESOLUTE
US and RESOLUTE Asia prospective, observational, nonrando-
mized,multicenter trials that enrolled patients from29 sites across
theUnited States (U.S.) and 17 sites across Asia. Patients enrolled in
both studies who received at least one 38-mm Resolute DES in a
lesion ≤35 mm in length and reference vessel diameter of 3.0–
4.2 mm were included in the 38-mm substudy. Up to two lesions
(in separate vessels) could be treated.
Results and conclusion: A total of 223 patients (114 in RESOLUTEUS
and 109 in RESOLUTEAsia)were enrolled. Average agewas 61 years
old, 38% had diabetes mellitus, 54% had double or triple vessel
disease, and 32% had prior myocardial infarction. Most (91%)
treated lesions were American Heart Association Class B2/C, total
stent length per patient was 44.6  14.3 mm, and reference vessel
diameter 2.8  0.4 mm. Three-year follow-up in 221 (99.1%)
patients has been previously presented: target lesion failure
(TVF) was 10.4% and comprised of 2.3% cardiac death (CD), 5.4%
target vessel myocardial infarction (TV-MI), and 4.1% target lesion
revascularization (TLR). The incidence of deﬁnite and probable
stent thrombosis (ST; Academic Research Consortium deﬁnition)
was 0.9% at 3 years. There was furthermore no difference at 3 years
between RESOLUTEAsia andRESOLUTEUS in the rates of TLR (1.9%
vs. 6.2%, p = 0.172), CD (0.9% vs. 3.5%, p = 0.370), TV-MI (4.6% vs.
6.2%, p = 0.769), or ST (0.9% vs. 1.8%, p > 0.999); however, TLF (5.6%
vs. 15.0%, p = 0.027) was lower in RESOLUTE Asia. The prespeciﬁed
analysis of RESOLUTE 38 mm substudy conﬁrmed the safety and
efﬁcacy of the 38 mm length Resolute DES at three years with no
observed increased risk for restenosis (TLR 4.1%) or stent throm-
bosis (0.9%) despite the longer stent length. Long-term outcomes at
four years will be available at Cardiological Society of India 2015 to
evaluate whether these low clinical adverse events with the 38-
mm length Resolute DES were sustained.
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Introduction: Left main coronary artery (LMCA) stenosis is con-
sidered an attractive target for balloon angioplasty because of the
vessel's large caliber, the lack of tortuosity, and the short lesion
length. Histologically, the LMCA has the most elastic tissue of the
coronary vessels, accounting for the poor response of the LMCA to
simple balloon angioplasty. However, coronary stents have been
shown to reduce the immediate need for coronary artery bypass
surgery (CABG) for abrupt vessel closure and likelihood of rest-
enosis after balloon angioplasty. Stenting of unprotected LMCA
stenosis is therefore considered a therapeutic option in selected
patients.
Case report: A 65-year-oldmale presented to uswith complaints of
chest pain, anxiety, and sweating. On examination, his pulse was
106 per minute, blood pressure was 110/80 mmHg, and chest was
clear. Other physical examinations were normal. ECG showed ST
segment depression in all leads except aVR lead, which showed
elevation. He was planned for coronary angiography.
His coronary angiography showed 90% stenosis of LMCA and 60%
stenosis of LCX. He was planned for angioplasty and stenting to
LMCA. A XB 3.5 6F guiding catheter was used. Two balancedmiddle
weight (BMW) coronary wires were put in left anterior descending
artery and left circumﬂex artery. Lesion was predialated with
noncompliant balloon size 3.5 mm  10 mm at the pressure of
15 atm. Coronary stent size 4 mm  18 mm was deployed at the
pressure of 10 atm. Post-dilatation was done with noncompliant
balloon size 4 mm  10 mm at the pressure of 18 atm. Final result
was good and there was no residual stenosis and dissection.
Patient was stable and pain free after the procedure.
Implication to clinical practice: Coronary artery bypass surgery is
considered as the gold standard treatment of unprotected LMCA
disease. Over the last 20 years, improvement in stent technology
and operators experience explained the increased number of
reports on the result of percutaneous intervention for treatment
of LMCA lesion. Recent data comparing efﬁcacy and safety of PCIs
using drug eluting stents and coronary artery bypass surgery
showed comparable results in terms of safety and a lower need
of repeat revascularization procedure.
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Intravascular foreign bodies which are retained are a complication
of percutaneous procedures. Recently percutaneous retrieval of
intravascular foreign bodies has become a frequently used tech-
nique. Various intravascular foreign bodies include fragments of
central venous catheters (most common), knotted pulmonary
artery (Swan Ganz) catheters, lost guidewires or guidewire frag-
ments, misplaced embolization coils and metallic stents.
We present 3 cases of retrieval of devices from percutaneous
intervention.
 Retrieval of Innove wire,
 Retrieval of central venous catheter wire,
 Retrievel of central venous catheter.
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Background: In the last two decades, percutaneous techniques to
close cardiac defects have been developed. Owing to anatomical
relationship of conduction system and perimembranous ventri-
cular septal defect (PMVSD) location, there are reports of high
incidence of conduction disturbances and aortic regurgitation after
device closure. We aimed to evaluate the safety and efﬁcacy of
transcatheter device closure of PMVSDwith Amplatzer Duct Occlu-
der I (ADO) with special emphasis on conduction disturbance. ADO
I has no RV disc and long waist in comparison with other devices
and thus thought to produce less compression of surrounding
tissue and producing less conduction disturbances.
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